Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-028328

Chief Commercial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Maduck Sean Chief Commercial Officer 2021-07-13 Option exercise +10,000 $2.24 $22,400 40,024 D
Derivatives
Maduck Sean Chief Commercial Officer 2021-07-13 Option exercise · Stock Option (Right to Buy) −10,000 15,000 D
Loading xslF345X03/doc4.xml…